By regulating alternative splicing, ESRP1 promotes expression of epithelial cell-specific variants of several genes such as CD44,18, 24ENAH (or hMena)25 and FGFR2,15 thereby having a role in tumor progression. Here, FGFR2 is linked to neoplasm.